Natural Product: NPC482722

Natural Product IDNPC482722
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
PDSBBERBJSPJMP-KOHBGNNASA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PDSBBERBJSPJMP-KOHBGNNASA-N
Standard InCHI InChI=1S/C48H74O19/c1-19-26(50)27(51)32(56)40(62-19)64-25-18-43(2,3)17-21-20-16-22(49)37-46(7)12-11-24(44(4,5)23(46)10-13-48(37,9)47(20,8)15-14-45(21,25)6)63-42-36(31(55)30(54)35(66-42)39(60)61)67-41-33(57)28(52)29(53)34(65-41)38(58)59/h16,19,21,23-37,40-42,50-57H,10-15,17-18H2,1-9H3,(H,58,59)(H,60,61)/t19-,21-,23-,24-,25+,26-,27+,28+,29+,30+,31+,32+,33-,34+,35+,36-,37+,40-,41+,42-,45+,46-,47+,48+/m1/s1
SMILES C[C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O[C@H]1CC(C)(C)C[C@@H]2C3=CC(=O)[C@H]4[C@]5(C)CC[C@H](C(C)(C)[C@H]5CC[C@]4(C)[C@@]3(C)CC[C@]12C)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O1)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O1)O)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   954.48 Volume:   926.781
?
Van der Waals volume.
Dense:   1.03 LogP:   1.275
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.896
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.094
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   8.0 Rigid Bonds:   47.0
TPSA:   308.89
?
Topological Polar Surface Area.
H-Bond Acceptor:   19.0
H-Bond Donor:   10.0 Rings:   8.0
Heavy Atoms:   19.0

MedChem Properties

QED Drug-Likeness Score:   0.152 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   6.412 Fsp3:   0.896
MCE-18:   181.319
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.716 Fluc inhibitor:   0.003
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.089
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.207 Promiscuous compounds:   0.277

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.021 MDCK Permeability:   -5.075
Pgp-inhibitor:   0.0 Pgp-substrate:   0.022
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.009
20% Bioavailability (F20%):   0.032 30% Bioavailability (F30%):   0.004
50% Bioavailability (F50%):   0.948

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.873
Plasma Protein Binding (PPB):   54.915% Volume Distribution (VD):   -0.44
Fu: 35.475%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.967
OATP1B3 inhibitor:   0.522 BCRP inhibitor:   0.0
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.935 CYP3A4-substrate:   0.827
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.827
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -0.043 Half-life (T1/2):  4.415

ADMET: Toxicity

hERG Blockers:  0.004 hERG Blockers (10um):  0.017
Human Hepatotoxicity (H-HT):  0.382 Drug-induced Liver Injury (DILI):  0.925
AMES Toxicity:  0.405 Rat Oral Acute Toxicity:  0.025
Maximum Recommended Daily Dose:  0.008 Skin Sensitization:  0.997
Carcinogencity:  0.005 Eye Corrosion:  0.0
Eye Irritation:  0.001 Respiratory Toxicity:  0.002
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.998
Hematotoxicity:  0.204 Drug-induced Nephrotoxicity:  0.991
Genotoxicity:  0.831 RPMI-8226 Immunitoxicity:  0.147
A549 Cytotoxicity:  0.027 Hek293 Cytotoxicity:  0.065
BCF:   0.451
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.652
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.623
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.572
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. DOI[10.1007/s11164-015-2099-x]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. DOI[10.1134/S1021443711030101]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. root n.a. PMID[16441081]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[16675659]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. root n.a. PMID[22074222]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[22074222]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. rhizome n.a. PMID[23867078]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. root n.a. PMID[23867078]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[24479468]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota roots n.a. n.a. PMID[24957203]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[25445757]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[25744461]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[26841168]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[32196343]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT152 Individual protein Nuclear factor erythroid 2-related factor 2 Homo sapiens FC = 1.53 n.a. PMID[26841168]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT742 Organism Influenza A virus Influenza A virus IC50 = 39600.0 nM PMID[26841168]
NPT742 Organism Influenza A virus Influenza A virus Activity = 47.0 % PMID[26841168]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC482722 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC471963
0.7959 Intermediate Similarity NPC285091
0.78 Intermediate Similarity NPC482744
0.75 Intermediate Similarity NPC482735
0.7449 Intermediate Similarity NPC482750
0.7379 Intermediate Similarity NPC482734
0.7379 Intermediate Similarity NPC182342
0.7379 Intermediate Similarity NPC482727
0.7379 Intermediate Similarity NPC471964
0.7228 Intermediate Similarity NPC482747
0.7228 Intermediate Similarity NPC202666
0.7228 Intermediate Similarity NPC471961
0.7228 Intermediate Similarity NPC242015
0.7228 Intermediate Similarity NPC482717
0.7075 Intermediate Similarity NPC482740
0.7027 Intermediate Similarity NPC482739
0.6964 Remote Similarity NPC482736
0.6964 Remote Similarity NPC482738
0.6952 Remote Similarity NPC482729
0.6952 Remote Similarity NPC482742
0.6916 Remote Similarity NPC247315
0.6916 Remote Similarity NPC482728
0.6852 Remote Similarity NPC482737
0.6757 Remote Similarity NPC471962
0.6667 Remote Similarity NPC482755
0.6514 Remote Similarity NPC262199
0.6509 Remote Similarity NPC482741
0.6509 Remote Similarity NPC482745
0.6509 Remote Similarity NPC482743
0.6509 Remote Similarity NPC146753
0.6449 Remote Similarity NPC471965
0.6449 Remote Similarity NPC482749
0.6436 Remote Similarity NPC482752
0.6364 Remote Similarity NPC95437
0.6306 Remote Similarity NPC114692
0.6273 Remote Similarity NPC131469
0.6091 Remote Similarity NPC14617
0.6053 Remote Similarity NPC187618
0.5963 Remote Similarity NPC482746
0.5847 Remote Similarity NPC313110
0.569 Remote Similarity NPC477075
0.5688 Remote Similarity NPC309780
0.5526 Remote Similarity NPC251768
0.5472 Remote Similarity NPC471967
0.5378 Remote Similarity NPC120116
0.5357 Remote Similarity NPC275343
0.5339 Remote Similarity NPC236657
0.5312 Remote Similarity NPC258617
0.5294 Remote Similarity NPC301449
0.5294 Remote Similarity NPC218954
0.5294 Remote Similarity NPC477076
0.5294 Remote Similarity NPC477079
0.5294 Remote Similarity NPC601290
0.5254 Remote Similarity NPC64715
0.5175 Remote Similarity NPC472949
0.5175 Remote Similarity NPC157868
0.5138 Remote Similarity NPC480937
0.5124 Remote Similarity NPC477077
0.5124 Remote Similarity NPC477078
0.5091 Remote Similarity NPC480943
0.5088 Remote Similarity NPC482748

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC482722 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7228 Intermediate Similarity NPD8328 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data